Future Cannabis Strategies Europe 2022
The Chelsea Harbour Hotel
26th-27th January, 2022
Sign Up for Agenda Updates
Future Cannabis Strategies Europe 2022
Welcome to our Future Cannabis Strategies Conference
Join us as we bring together strategic business leaders from the European Consumer-Facing Cannabis products category. We will explore the CBD industry including Cannabis Products & Devices, Beverages, Tobacco, Cosmetics & Nutraceuticals, together with solution providers for 2 full days of insight, discussion and debate into how manufacturers can:
- Capitalise on the growing UK & European market
- Navigate through legalisation on the sale of edibles, extracts and topicals
- Understand the need for education surrounding cannabis to promote cannabis products in both medical and consumer concepts
- Spotlight growth in International markets including the UK, Mainland Europe & the Americas
- Understand consumer trends & demands
- Identify opportunities to introduce Cannabis/ THC / Hemp infused products into existing Consumer Packaged Goods (CPG)
- Review recent product innovation to understand how market trends are adapting to consumer demands
- Look at the future of the industry to devise strategies for a successful category long term
- Understand key areas for growth and investment among the cannabis sector
The Future Cannabis Strategy Conference brings together key opinion leaders from some of the biggest brands in the industry with an exciting mix of large–mid-small sized disruptive companies that have shaken up the category with new offerings and methods. We look at the future of cannabis Europe wide, following on from its success in North America.
Join us for intellectually driven presentations with a mix of case studies, panels and keynotes, attendees will learn how to devise strategies, learn from successful companies and implement new methodologies that ensure successful growth and development across a variety of cannabis categories. The category needs to unite and connect to push the cannabis sector to a more fruitful and wider acceptance among consumers. There is ample opportunity for networking, Q&A sessions and exploring solutions providers who may have the answer to some of the most pressing issues at present.
What to Expect?
Hear from some of the biggest and most innovative brands in your market. Learn what is round the corner in terms of future trends, NPD, product innovation and opportunities for growth.
Hear from a mixture of the biggest brands including as well as new and upcoming disruptors.
Equip yourself for the next 12 months by hearing about new trends in flavours, product types, growth areas and understanding what consumers want.
250+
Attendees
20+
Exhibitors
80%
Attendees at Director + level
Why attend?
Discover
-
Identify gaps in the market born of new regulations, growing trends and emerging opportunities as well as key insights relating to consumer demands that can be leveraged in order to increase brand relevance and ensure success.
Network
-
Meet CEOs, Managing Directors, Commercial Directors, Heads of R&D and Global Expansion and many more from some of the biggest brands in the industry as well as the most exciting disruptive start – ups in this intellectually driven conference that will better prepare you for the rapidly developing beverage landscape.
Inspire
-
Take away experiences and insights from your cannabis sector peers so that you can feel confident in your 2021 strategy and beyond by changing course for a more resilient and robust business strategy as the cannabis market continues to strengthen

Franziska Katterbach
President,Khiron Life Sciences Europe
Biography: Franziska Katterbach is an accomplished business executive and legal expert (zugelassene Rechtsanwältin) who brings extensive experience working within Europe's emerging cannabis industry. After completing her legal studies at Universität Leipzig and Landgericht Darmstadt, Franziska joined the corporate law firm Dentons, where she was involved in high-profile deals in the cannabis sector across multiple jurisdictions. Franziska later served as Director of Legal for Canopy's European operations, before joining Khiron. With 8+ years of regulatory expertise and 4+ as business executive in the European emerging cannabis industry, Franzska has well rounded knowledge in the industry. Franziska is considered a pioneer of the medical cannabis market in Germany, working in the medical cannabis industry in Europe on executive level since the very beginning in 2016.
Session Details: Catalysts to grow the European Medical Cannabis Market (faster) 26-01-2022, 11:45 am View In Agenda

Golan Bitton
CEO & Co-Founder,Univo Pharmaceuticals
Biography: Golan is leading the Univo Pharmceutical talented and experienced team. At Univo Pharmceutical we take pride in our work and strive for consistent excellence. Golan has over 20 years of senior managerial roles in the Israel Ministry of Defense and as an officer in the IDF Special Forces. Golan Implemented and managed large scale multi-million dollar projects for the Israel Government. ☘ Univo Pharmceutical - Our Goals is to grow high-quality cannabis, in particular, to develop new cannabis strains and produce a wide range of GMP grade cannabis-based products for distribution and export to international markets. ☘ Univo Pharmceutical- Using one of the largest *cannabis databases* we are able to cater to the individualized needs of our customers and match the specific multi-faceted cannabis strain best suited to their individual needs. ☘ Univo Pharmceutical- Innovative *scientific formulas* Provides wide range of cannabis-based products, which are developed using new and innovative *scientific formulas*.
Session Details: In & Out: Opportunity in Cannabis Across the Continent 26-01-2022, 10:45 am View In Agenda

Avihu Tamir
Founder and CEO,Kanabo
Biography:
Mr Tamir founded Kanabo Research in 2016 and since then has served as its CEO of the company. He has led the company to list on London Stock Exchange by way of RTO, formulating Kanabo Group, Plc as the first public medical cannabis company in the UK. His expertise includes biotechnology, new agriculture and agro-tech, and other breakthrough technologies in the dynamic field of Medical Cannabis.
Session Details: “Just the Beginning”: Cannabis & The Real Growth 27-01-2022, 11:15 am View In Agenda

Catherine Wilson
UK Representative & Member of the Board of Advisors,European Industrial Hemp Association
Biography: Catherine is UK Representative & Member of the Board of Advisors of the European Industrial Hemp Association. EIHA was formed 19 years ago and is the only pan-European membership organization in the industrial hemp sector. Our secretariat offices in Brussels and the UK representation protect and support our membership of 200+, primarily farmers, processors and manufacturers; representing the entire chain from seed to shelf. Our primary objective is to monitor EU/UK hemp related policies and to provide the decision makers with accurate and reliable information across different spheres of competencies. Currently we monitor the following policies: CAP reform, Hemp extracts/Novel Food regulation, THC limits in feed and food, Life Cycle Assessment of hemp materials, CO2 impacts, environmental concerns and cosmetics. In addition, EIHA formed the largest novel food consortium and pending a successful outcome, EIHA consortium member company's products will be allowed to be marketed in the UK/EU with an exclusivity on the study that will last 5 years.
Session Details: Hemp, the whole plant: Latest legislative update covering EU and UK 26-01-2022, 9:00 am Championing Sustainability in Cannabis for Europe A deep dive into regulatory perspectives and financing the sector: An overview of where we are and the visions going forward 27-01-2022, 10:15 am View In Agenda

Paul Gurney
Managing Director, Equity Sales Europe & Asia Pacific,BMO Capital Markets
Biography: Paul Gurney is a Managing Director at BMO Capital Markets in London, UK, leading BMO’s coverage of large institutional equity clients in Europe and Asia Pacific. Paul has 15 years of capital markets experience, researching companies, syndicating transactions, structuring deals, and providing value-added advice to institutional and corporate clients across multiple sectors. In early 2018, Bank of Montreal (BMO) became the first major bank to underwrite the cannabis sector, leading a US$175m equity financing for the world’s largest cannabis company, Canopy Growth. Paul has been closely involved in the sector in Europe ever since, helping raise US$153m for Tilray, the first ever NASDAQ listed cannabis company, and the third best performing IPO in the US in 2018. Paul spearheads BMO’s investment efforts for cannabis companies in Europe, and Australia, introducing investors to sector heavyweights like Aphria, Aurora, Canopy Growth and Tilray, while actively developing the next generation of pre-IPO cannabis companies. Paul’s early involvement in the sector has helped him develop a deep network of industry and client contacts, making him one of the thought leaders for the sector in Europe.
Session Details: Championing Sustainability in Cannabis for Europe A deep dive into regulatory perspectives and financing the sector: An overview of where we are and the visions going forward 27-01-2022, 10:15 am View In Agenda

Tim Phillips
Managing Director,ECigIntelligence
Biography: Tim Phillips is the Managing Director of Tamarind Intelligence, publisher of leading business intelligence services ECigIntelligence, CBD-Intel and TobaccoIntelligence. These independent market data and regulatory tracking and analysis services for the vape, CBD and tobacco-alternatives industries provide market-leading insights into the sectors they cover for clients ranging from governments and academic institutions to multinational companies and professional service providers. Tim Phillips is a UK-qualified attorney, having worked at the European Commission, international law firm Herbert Smith, media companies BSkyB and AOL, and Betfair, where he worked in various legal and government relations roles as the company went through its IPO. He was also a partner in a New York venture capital-funded start-up in the diamond sector. Tim holds a postgraduate diploma in legal practice from the University of Law, London and a masters degree in geology from Oxford University. He has run for Tamarind Intelligence for the past 6 years.
Session Details: View In Agenda

Stuart McKenzie
CEO,Reakiro
Biography: Reakiro founder and Serial entrepreneur with proven International success records within the FMCG, Marketing, Entertainment and Distribution Industries working alongside some of the worlds largest Multinational companies.
Session Details: Case Study: Bringing together a wealth of experience from retail and the Cannabis Sector 26-01-2022, 12:15 pm View In Agenda

Hilary Leam
International Business Development Director,Reakiro
Biography: For over 25 years Hilary has developed brands across the health, wellness, and beauty sectors. Hilary has now chosen to channel her innovative direction and creation into the CBD industry, which is not only a new venture but an intersection of all her prior experiences.
Session Details: Case Study: Bringing together a wealth of experience from retail and the Cannabis Sector 26-01-2022, 12:15 pm View In Agenda

Mark Wright
Head of Operations,Reakiro
Biography: An internationally experienced executive with Corporate and Entrepreneurial experience. A career across 6 different countries, including developing markets, in a range of business sectors, and an ability to deliver above expectation results.
Session Details: Case Study: Bringing together a wealth of experience from retail and the Cannabis Sector 26-01-2022, 12:15 pm View In Agenda

Toby Gordon-Smith
CEO,Grass & Co
Biography:
Toby is an ex-management consultant and veteran of the health supplements industry and has been at the helm of Grass & Co. since early 2019. Leading this dynamic, fast-growing business, Toby’s role has been to establish a trusted, premium British CBD brand with a strong platform for continuing growth. The award-winning range combines the highest quality CBD blended with complementary botanicals and vitamins to produce the best tasting CBD oils.
Under Toby’s leadership, Grass & Co. has secured high profile retail listings including Holland & Barrett, Ocado, Amazon, Revital, as well as driving direct sales through the brand’s own e-commerce site.
With a background steeped in knowledge of the health and consumer goods industries, Toby previously spent seven and a half years as Strategy Director for Glanbia’s Performance Nutrition division in EMEA, and prior to this at Diageo where he worked in Global Business Support across India, Vietnam, France, Poland, Turkey and Mexico. He also spent time at Bain, a management consultancy well known for its entrepreneurial ethos. Toby holds an Engineering degree from the University of Cambridge.
Session Details: PANEL How the Pandemic Pushed Innovation: The Power of NPD Cross Category 26-01-2022, 3:30 pm View In Agenda

Rebekah Hall
CEO ,South West Brands
Biography:
Session Details: CBD Products on the Shelf, for Greater Health 26-01-2022, 9:30 am PANEL Future Cannabis Investment: Getting that funding 26-01-2022, 10:00 am View In Agenda

Lars Müller
CEO,SynBiotic SE
Biography: Lars Müller has been an entrepreneur since the age of 15 and is currently one of the youngest CEOs of a publicly traded cannabis company. With SynBiotic SE, he is building a European platform to drive the research and development of new cannabinoid and terpene-based solutions to major societal problems such as pain, sleep and anxiety.
Session Details: View In Agenda

Clifton Flack
Founder and CEO,CiiTECH
Biography:
Session Details: Is it all about the hype? The emergence and convergence of CBD & THC 27-01-2022, 3:00 pm View In Agenda

Matthew J. Nordgren
CEO & Managing Partner,Arcadian Capital
Biography:
Session Details: PANEL Future Cannabis Investment: Getting that funding 26-01-2022, 10:00 am Worldwide Financial Forecast: The Cannabis Industry in 2022 & Beyond 27-01-2022, 3:30 pm View In Agenda

Olivia Ferdi
Co-Founder,TRIP
Biography:
Session Details: PANEL High Spirits: The Rise of Cannabis in Alcoholic Beverages 26-01-2022, 2:15 pm PANEL How the Pandemic Pushed Innovation: The Power of NPD Cross Category 26-01-2022, 3:30 pm View In Agenda

Tom Lorimer
Co-Founder,OTO
Biography: Tom has over 10 years experience in FMCG across a breadth of categories. Most recently though, he and a team of like-minded entrepreneurs, product scientists and brand builders grouped together to form OTO International Ltd. OTO, which translates as 'sound' in Japanese, aims to help people discover the amazing power of CBD through thoughtful and effective products that easily and enjoyably fit into our daily lives. Tom has been spear-heading OTO's growth into new territories and is looking at continued ways to ensure OTO remains the thought, brand and market leader in this growing space.
Session Details: PANEL How the Pandemic Pushed Innovation: The Power of NPD Cross Category 26-01-2022, 3:30 pm View In Agenda

Hamish Clegg
CEO,Hilltop Leaf
Biography:
Session Details: PANEL Reinforcing the Spirit of Togetherness: Creating a profitable and beneficial category for all 27-01-2022, 9:30 am View In Agenda

Ulla Haaning Singapuri
Share Holder,KannaSwiss
Biography:
Session Details: PANEL Future Cannabis Investment: Getting that funding 26-01-2022, 10:00 am PANEL Reinforcing the Spirit of Togetherness: Creating a profitable and beneficial category for all 27-01-2022, 9:30 am View In Agenda

Nick Pateras
Managing Director, Europe,Materia
Biography: Nick Pateras is Managing Director, Europe at Materia, where he oversees the company’s operations across Germany, Malta and the UK. Materia is an EU GMP certified manufacturer and distributor of medical cannabis and CBD products across the burgeoning European market. Previously, Nick served as Vice President, Strategy at Lift & Co., Canada’s leading cannabis education and insights platform. He is a regular speaker at cannabis conferences across North America and Europe and taught the Cannabis Business Fundamentals course at George Brown College in Toronto in 2018-19. Prior to his time in cannabis, Nick spent several years in the pharmaceutical sector with Johnson & Johnson Inc, managing various category-leading OTC and Health & Beauty businesses.
Session Details: PANEL Future Cannabis Investment: Getting that funding 26-01-2022, 10:00 am View In Agenda

David Curry
VP of Public Relations,Instadose Pharma
Biography: David Curry has had a varied career that has taken him around the world. He has been involved in a number of tech businesses with his serial entrepreneur wife, working on everything from tech infrastructure to fund raising seed capital in a range of applications. Starting out as an Officer in the Canadian Navy he left that to pursue a career in Opera and Musical Theatre which as a principal has appeared in over 2000 performances in 27 countries. The world of Opera provided access at a very high level to a unique group of people which include business leaders and policy makers which has offered invaluable insight and perspective. Covid19 provided an impetus to merge and apply his unique talents to tell the story of the evolution of the burgeoning world of the global cannabis trade.
Session Details: View In Agenda

John Upton
Product Specialist,Agilent Technologies
Biography: John began his work in mass spectrometry over 25 years ago designing Time of Flight systems for the study of rapid combustion processes. From there he went on to work on the design of atmospheric pressure external ion source systems for quadrupole based analyzers. John gained experience of ion trap systems prior to moving onto triple quadrupole configurations and business applications. Throughout his career, John has held a number of positions, including research fellow, application chemist, development physicist, sales specialist and group manager. Having been with Agilent Technologies for over 10 years, he is currently responsible for gas phase and mass spectrometry within the International Distributor Organization. John holds a BSc (Hons) in Chemistry and Biochemistry, and a PhD in Physical Chemistry
Session Details: The Analysis of Cannabis Materials within a Framework of National and European Regulation 26-01-2022, 12:45 pm View In Agenda

Craig Hutchison
CEO & Founder,CEDER'S Alt-Gin, CELTIC SOUL Dark Spirit, MARIE LAVEAU Alt-Rum, M&C's CBD Botanical Spirit
Biography: As a previous drinks industry executive, Craig developed the strategy, built the structure, & implemented the RTM & brand plans for Pernod Ricard's charge into Africa. Before that he was Strategy Director for Absolut, Malibu and Kahlua, driving the strategic plan & brand development strategy. Since leaving the drinks world in 2015 he has been involved in business process outsourcing to Africa, setting up a values-based, people management web-platform, and consulting. He also presents on futurology; how our lives are going to change dramatically over the coming decades. Early 2017, Craig (South African) and his wife Maria (Swedish) discovered a magical valley, home to many intriguing botanicals, in the Cederberg mountains, just north of Cape Town. The valley, which they now co-own, inspired them to distil rare Cape & classic gin botanicals, and then blend with pristine Swedish water. The result is CEDER'S, a distilled non-alcoholic alt-gin, your Everyday Escape. Craig also launched CELTIC SOUL in July 2019, a distilled non-alcoholic dark spirit, and has a few more brands in the pipeline, including a non-alcoholic rum and a CBD Botanical Spirit. Watch this space.
Session Details: PANEL High Spirits: The Rise of Cannabis in Alcoholic Beverages 26-01-2022, 2:15 pm View In Agenda

Andrea Properzi
Quality Manager,Fundacion CANNA
Biography: Andrea Properzi is a chemist and works as a quality manager at the Fundación CANNA. Born in the Italian Alps, he moved to Padua (UNIPD) to continue his studies (Inorganic Chemistry). In 2013, Andrea moved to Barcelona and contributed to the development of systems that minimized health-related risks for both the operator and the consumer of biologically derived products. In the last years, in Barcelona, Andrea has helped to manage the projects/programs out of routine analytical practices.
Session Details: PANEL How the Pandemic Pushed Innovation: The Power of NPD Cross Category 26-01-2022, 3:30 pm View In Agenda

Kim Smith
Director & Co-Founder,KLORIS CBD
Biography:
Session Details: PANEL How the Pandemic Pushed Innovation: The Power of NPD Cross Category 26-01-2022, 3:30 pm View In Agenda

Pedram Mehrshahi
Director,Kloris CBD
Biography:
Session Details: PANEL Reinforcing the Spirit of Togetherness: Creating a profitable and beneficial category for all 27-01-2022, 9:30 am View In Agenda

Matt McNeill
Founder,KLORIS
Biography:
Session Details: PANEL Reinforcing the Spirit of Togetherness: Creating a profitable and beneficial category for all 27-01-2022, 9:30 am View In Agenda

Hector McNeil
Co-CEO & Founder,Hanetf
Biography:
Session Details: Forging a New Path for Global Cannabis Industry through Investment 27-01-2022, 11:45 am View In Agenda

Daniel McMillan
Sr Market Development Manager, EMEAI,SCIEX
Biography:
Session Details: Defining robustness in pesticide and mycotoxin analysis of cannabis matrices 27-01-2022, 12:15 pm View In Agenda

Rosie Joly
Co-Founder & Beauty & Wellness Director,OTO
Biography:
Session Details: Canna Beauty: The Demand for Innovative Cosmeceuticals that work 27-01-2022, 2:00 pm View In Agenda

Ian Greenfield
Sales Manager,JuicyFields
Biography: Originally hailing from Berkshire in England, Ian Greenfield spent over 10 years working in the advertising industry in London, before realising his long-held ambition of working in the cannabis industry, after moving to Berlin in 2017. He is passionate about democratising cannabis and making its benefits available to all.
Session Details: JuicyFields: Growing the Future of Medical Cannabis 26-01-2022, 4:15 pm View In Agenda

Zvezda Lauric
Chief Communication Officer,JuicyFields
Biography: Zvezda Lauric comes from a journalism background with multiple appearances on various television channels across Latin America. Her passion for educating people in medical cannabis comes from a personal connection with her mother being ill - she quickly understood that the cannabis plant can be used as a powerful medicine. Today, she is working on removing the stigmas around cannabis and also supporting women in the industry, hoping that more women will have the courage to break barriers in the cannabis industry
Session Details: View In Agenda















The Cannavist
SPONSORSHIP OPPORTUNITIES
Valentin Gerasimuk
Head of Business Development, Consumer Events
T: +44 (0) 207 936 6794
E: Valentin.Gerasimuk@arena-international.com
SPEAKING OPPORTUNITIES
Amy Avanzato
Conference Producer
T: +44 (0) 207 9366 605
E: amy.avanzato@arena-international.com